Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment - Neuro-Psycho-pharmacologie des systèmes dopaminergiques sous-corticaux Accéder directement au contenu
Article Dans Une Revue Drug Discovery Today Biosilico Année : 2014

Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment

Résumé

Bipolar disorder (BD) is one of the world's ten most disabling conditions. More options are urgently needed for treating bipolar depressive episodes and for safer, more tolerable long-term maintenance treatment. We reviewed 30 recent clinical trials in depressive episodes (eight tested compounds) and 14 clinical trials in maintenance treatment (ten tested compounds). Positive results in Phase III trials, regulatory approval and/or new therapeutic indications were obtained with some of the developing drugs, particularly for depressive episodes. The current BD pipeline is encouraging with promising new compounds, acting on novel pharmacological targets and on specific aspects of bipolar depression.
Fichier non déposé

Dates et versions

hal-02173549 , version 1 (04-07-2019)

Identifiants

Citer

Ricardo P Garay, Pierre-Michel Llorca, Allan H. Young, Ahcene Hameg, Ludovic Samalin. Bipolar disorder: recent clinical trials and emerging therapies for depressive episodes and maintenance treatment. Drug Discovery Today Biosilico, 2014, 19 (11), pp.1792-1800. ⟨10.1016/j.drudis.2014.07.010⟩. ⟨hal-02173549⟩
47 Consultations
1 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More